Head-to-head for women
Henry Meds vs Hers
Henry Meds and Hers both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Metabolic-Fit Score — our women's-health rubric.
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.
Henry Meds
Higher scoreMetabolic-Fit 81/100 · Grade B−
Metabolic-Fit / 100
Best for: Someone comfortable with the stated plan commitment who confirms the full prescribed treatment cost before paying.
Visit Henry MedsHers
Metabolic-Fit 63/100 · Grade C
Metabolic-Fit / 100
Best for: Mothers who want a familiar, app-driven consumer brand and are comfortable budgeting for a separate membership fee on top of the posted medication price.
Visit HersThe verdict for women
Henry Meds edges out Hers on the Metabolic-Fit Score, 81 to 63 (B− vs C). Someone comfortable with the stated plan commitment who confirms the full prescribed treatment cost before paying.
Hers is still a genuine option — an FDA warning letter dated September 2025, over the compounded-semaglutide business it has since left behind. One of the few mass-market brands designed around a woman's front door — now selling FDA-approved brand Wegovy and Zepbound instead of the compounded semaglutide it used to, though the posted price is only half the bill once the required $149/mo membership is added. Weigh the six women's-health factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
Price highlights compare average monthly budgets, using 52 weeks ÷ 12 months for weekly cycles. Quoted charges retain their billing units; unknown periods and fee-only or prepaid quotes do not compete.
| Detail | Henry Meds | Hers |
|---|---|---|
| Metabolic-Fit Score | 81/100 · B− | 63/100 · C |
| Overall rank | #7 | #33 |
| Semaglutide | $297/mo | $149/mo Wegovy Pill + $149/mo membership (~$298/mo all-in) |
| Tirzepatide | Oral: $891 prepaid for a listed 3-month supply; injection price unconfirmed | $299/mo Zepbound + $149/mo membership (~$448/mo all-in) |
| Coverage | Multi-state | Not available in all 50 states; no complete list published |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
The decision beyond the score
A nearly identical starting bill can buy a different product
Henry Meds lists compounded semaglutide injections at $297 monthly. Hers' starting Wegovy pill total is approximately $298, combining $149 medication with the required $149 monthly membership. Those figures differ by only a dollar, but the products and fee structures differ substantially. The Hers option is an FDA-approved brand tablet; Henry's offer is a compounded injection. Neither should be selected solely because the payments happen to be close. Ask the prescriber which product is appropriate, what dose is being quoted and whether the starting drug price will continue as treatment changes.
Hers also lists brand injections: a Wegovy pen starting total of about $348 and Zepbound starting around $448, both including the ordinary $149 membership. The first-month membership is $39, which changes the initial total without reducing the regular membership charge. Henry's lower semaglutide injection equivalents instead come from prepayment: $1,482 for six months or $2,364 for twelve. A lower first membership fee and a longer prepaid drug supply solve different budgeting problems. Write down the second charge and the full commitment rather than comparing the first highlighted number.
Oral choice and regulatory history deserve separate attention
Henry offers compounded sublingual semaglutide programs at $249 or $179 for a distinct lower-dose option. It also advertises oral tirzepatide at $891 prepaid for a listed three-month supply, although that section contains conflicting duration language. A current Henry injectable tirzepatide price was not established. Consequently, Hers' Zepbound amount cannot be described as a premium over a confirmed Henry injection total. Someone who wants to avoid needles should compare the exact oral formulation and its evidence with the prescribing clinician, including the difference between compounded preparations and the approved Wegovy pill.
Hers carries a September 2025 FDA warning letter relating to its former compounded-semaglutide business. Its present brand-name menu should be understood alongside that history, rather than implying the historical letter concerns the same current finished products. Both companies have geographic eligibility limits that need checking for your address. Hers' women-focused presentation also does not establish dedicated postpartum or PCOS care; Henry's program is not organized around those concerns either. The stronger choice depends on prescribed product, an affordable continuing total and a clear agreement about follow-up, with neither a familiar brand nor a similar monthly number settling those questions.
Based on the public terms documented in the Henry Meds review and Hers review. Each review details the prices and terms. Confirm current terms before paying.
Metabolic-Fit / 100
Henry Meds
Metabolic-Fit 81/100 · Grade B−
What we like
- An established operator with a long, visible track record
- Some states allow an independent provider review without a scheduled video call
- Semaglutide: $297/mo; tirzepatide: Oral: $891 prepaid for a listed 3-month supply; injection price unconfirmed.
The caveats
- Compounded only, and no pregnancy or postpartum framing
- The oral tirzepatide section lists a three-month supply at $891 paid in full, but its delivery text conflicts on duration; injectable tirzepatide pricing needs confirmation.
Metabolic-Fit / 100
Hers
Metabolic-Fit 63/100 · Grade C
What we like
- Explicit women-focused positioning and a brand many mothers already trust
- Now selling FDA-approved brand-name medication (Wegovy, Zepbound) rather than compounded semaglutide
- An app with oral and injectable brand-name options; availability varies by state.
The caveats
- Carries an FDA warning letter dated September 2025 over the prior compounded-semaglutide business, before this pivot to brand-name product
- The posted 'from $149/mo' price is medication only — a required $149/mo membership (billed separately, $39 the first month) roughly doubles the real ongoing cost
- A general weight program, not a clinician-led metabolic service with postpartum or PCOS specialization
Some outbound links earn MomMetabolic a referral fee at no added cost to you, walled off from the Metabolic-Fit Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Comparisons close to Henry Meds vs Hers.
- Form Health vs Hers
- Hers vs Zealthy
- Hers vs Ro
- CoreAge Rx vs Pallas Health
- CoreAge Rx vs Found Health
- CoreAge Rx vs SynergyRX
Or browse the full comparison hub.